Dose-related visual-field defects in patients receiving PUVA therapy

Sunlight exposure behaviour and vitamin D status in photosensitive patients: longitudinal comparative study with healthy individuals at U.K. latitude.

The British journal of dermatology·2014

Mycosis fungoides masquerading as cutaneous lupus erythematosus and associated with antiphospholipid syndrome.

Clinical and experimental dermatology·2007

Delta 9-tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed.

British journal of pharmacology·2007

Correlates of health care utilization among HIV-seropositive injection drug users.

AIDS care·2006

Monitoring the European standard series in 10 centres 1996-2000.

Contact dermatitis·2005

Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?

The Journal of pharmacy and pharmacology·2004

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

New paradigm of therapeutic antibiotic monitoring.

Casopis lekaru ceskych·2026

Improving drug therapy safety through pictograms: opportunities, limitations and future prospects-a survey of healthcare professionals.

European journal of hospital pharmacy : science and practice·2026

Formation of a pulmonary drug-depot by a double-ester treprostinil prodrug enables sustained lung-selective delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026

ETODA: Automatic three-dimensional error tolerance grid generation for dosage adaptation in precision medicine.

Computer methods and programs in biomedicine·2026

Transitions From Parenteral Prostacyclin Analogues to Selexipag in Patients With Pulmonary Arterial Hypertension.

Pulmonary circulation·2026

A DoE-Dual centrifugation-driven screening platform for liposomal incorporation of poorly soluble APIs: Application to the PROTAC ACBI2.

International journal of pharmaceutics: X·2026

Related Experiment Videos

Dose-related visual-field defects in patients receiving PUVA therapy

Related Concept Videos

Sunlight exposure behaviour and vitamin D status in photosensitive patients: longitudinal comparative study with healthy individuals at U.K. latitude.

Mycosis fungoides masquerading as cutaneous lupus erythematosus and associated with antiphospholipid syndrome.

Delta 9-tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed.

Correlates of health care utilization among HIV-seropositive injection drug users.

Monitoring the European standard series in 10 centres 1996-2000.

Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

New paradigm of therapeutic antibiotic monitoring.

Improving drug therapy safety through pictograms: opportunities, limitations and future prospects-a survey of healthcare professionals.

Formation of a pulmonary drug-depot by a double-ester treprostinil prodrug enables sustained lung-selective delivery.

ETODA: Automatic three-dimensional error tolerance grid generation for dosage adaptation in precision medicine.

Transitions From Parenteral Prostacyclin Analogues to Selexipag in Patients With Pulmonary Arterial Hypertension.

A DoE-Dual centrifugation-driven screening platform for liposomal incorporation of poorly soluble APIs: Application to the PROTAC ACBI2.

Related Experiment Videos

Dose-related visual-field defects in patients receiving PUVA therapy

Related Concept Videos

Related Articles